PURPOSE: Left ventricular (LV) mechanical dyssynchrony (LVMD) was assessed by gated single-photon emission CT myocardial perfusion imaging (MPI) as an independent predictor of death from any cause in patients with known coronary artery disease (CAD) and reduced LV function. METHODS: Between 2001 and 2010, 135 patients (64 ± 11 years of age, 84 % men) with known CAD, reduced LV ejection fraction (LVEF, 38 ± 15 %) and without an implanted cardiac resynchronization therapy device underwent gated MPI at rest. LV functional evaluation, which included phase analysis, was conducted to identify patients with LVMD. Kaplan-Meier survival curves were calculated for death of any cause during a mean follow-up of 2.0 ± 1.7 years. Uni- and multivariate Cox proportional hazards regression models were calculated to identify independent predictors of death from any cause. RESULTS: Of the 135 patients, 30 (22 %) died during follow-up (18 cardiac deaths and 12 deaths from other causes). Kaplan-Meier curves showed a significantly shorter survival time in the patients with severely reduced LVEF (<30 %, n = 45) or with LVMD (n = 81, log-rank test P <0.005). Cox models identified LVMD, LVEF < 30 % and a total perfusion deficit at rest of ≥ 20 % as independent predictors of death from any cause. While patients with LVEF <30 % in conjunction with LVMD had similar survival times irrespective of whether they had early revascularization or medical therapy, those patients with LVEF ≥ 30% and LVMD who underwent revascularization had significantly longer survival. CONCLUSION: In patients with known CAD and reduced LV function, dyssynchrony of the LV is an independent predictor of death from any cause.
PURPOSE:Left ventricular (LV) mechanical dyssynchrony (LVMD) was assessed by gated single-photon emission CT myocardial perfusion imaging (MPI) as an independent predictor of death from any cause in patients with known coronary artery disease (CAD) and reduced LV function. METHODS: Between 2001 and 2010, 135 patients (64 ± 11 years of age, 84 % men) with known CAD, reduced LV ejection fraction (LVEF, 38 ± 15 %) and without an implanted cardiac resynchronization therapy device underwent gated MPI at rest. LV functional evaluation, which included phase analysis, was conducted to identify patients with LVMD. Kaplan-Meier survival curves were calculated for death of any cause during a mean follow-up of 2.0 ± 1.7 years. Uni- and multivariate Cox proportional hazards regression models were calculated to identify independent predictors of death from any cause. RESULTS: Of the 135 patients, 30 (22 %) died during follow-up (18 cardiac deaths and 12 deaths from other causes). Kaplan-Meier curves showed a significantly shorter survival time in the patients with severely reduced LVEF (<30 %, n = 45) or with LVMD (n = 81, log-rank test P <0.005). Cox models identified LVMD, LVEF < 30 % and a total perfusion deficit at rest of ≥ 20 % as independent predictors of death from any cause. While patients with LVEF <30 % in conjunction with LVMD had similar survival times irrespective of whether they had early revascularization or medical therapy, those patients with LVEF ≥ 30% and LVMD who underwent revascularization had significantly longer survival. CONCLUSION: In patients with known CAD and reduced LV function, dyssynchrony of the LV is an independent predictor of death from any cause.
Authors: Khaldoun G Tarakji; Richard Brunken; Patrick M McCarthy; M Obadah Al-Chekakie; Ahmed Abdel-Latif; Claire E Pothier; Eugene H Blackstone; Michael S Lauer Journal: Circulation Date: 2006-01-03 Impact factor: 29.690
Authors: Piotr J Slomka; Hidetaka Nishina; Daniel S Berman; Cigdem Akincioglu; Aiden Abidov; John D Friedman; Sean W Hayes; Guido Germano Journal: J Nucl Cardiol Date: 2005 Jan-Feb Impact factor: 5.952
Authors: Aju P Pazhenkottil; Ronny R Buechel; Lars Husmann; René N Nkoulou; Mathias Wolfrum; Jelena-Rima Ghadri; Janine Kummer; Bernhard A Herzog; Philipp A Kaufmann Journal: Heart Date: 2010-10-20 Impact factor: 5.994
Authors: Piotr J Slomka; David Fieno; Louise Thomson; John D Friedman; Sean W Hayes; Guido Germano; Daniel S Berman Journal: J Nucl Med Date: 2005-05 Impact factor: 10.057
Authors: John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: Maureen M Henneman; Ji Chen; Claudia Ypenburg; Petra Dibbets; Gabe B Bleeker; Eric Boersma; Marcel P Stokkel; Ernst E van der Wall; Ernest V Garcia; Jeroen J Bax Journal: J Am Coll Cardiol Date: 2007-04-05 Impact factor: 24.094
Authors: Sebastian Lehner; Christopher Uebleis; Franziska Schüßler; Alexander Haug; Stefan Kääb; Peter Bartenstein; Serge D Van Kriekinge; Guido Germano; Heidi Estner; Marcus Hacker Journal: Eur J Nucl Med Mol Imaging Date: 2013-08-01 Impact factor: 9.236
Authors: Fadi G Hage; Himanshu Aggarwal; Kanan Patel; Ji Chen; Arnold F Jacobson; Jaekyeong Heo; Ali Ahmed; Ami E Iskandrian Journal: J Nucl Cardiol Date: 2013-10-30 Impact factor: 5.952
Authors: Paul L Hess; Linda K Shaw; Sreekanth Vemulapalli; Robert Pagnanelli; Christopher M O'Connor; Salvador Borges-Neto Journal: J Nucl Cardiol Date: 2015-05-21 Impact factor: 5.952
Authors: Christopher Uebleis; Xaver Hoyer; Serge D Van Kriekinge; Franziska Schuessler; Rüdiger Paul Laubender; Alexander Becker; Sebastian Lehner; Andrei Todica; Alexander Haug; Peter Bartenstein; Paul Cumming; Guido Germano; Marcus Hacker Journal: J Nucl Cardiol Date: 2013-01-25 Impact factor: 5.952